This is what I was looking for, the 2021 meta analysis of the trials.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885725/
Despite all the controversy about HCQ and CQ use for COVID-19 treatment, this meta-analysis did not show any better outcomes in patients using HCQ or CQ when compared to the control group. The results showed no statistical significance in the treatment with HCQ or CQ in achieving virological cure and faster clinical recovery.
Conclusion.
These results suggest that the use of HCQ or CQ is not associated with decreased viral load, faster clinical recovery, improved survival, decreased need for mechanical ventilation, and decreased hospitalization time for patients with COVID-19. However, it suggests that the use of HCQ or CQ can be associated with an increased risk of adverse effects.
Obtuse indeed.